Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vinay Prasad
Biotech
FDA steers CAR-T developers toward randomized superiority trials
Under plans outlined by Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to show superiority over existing treatments.
Nick Paul Taylor
Dec 9, 2025 4:33am
Fierce Pharma
12 former FDA chiefs blast Prasad's vaccine policy shake-ups
Dec 4, 2025 10:36am
FDA unveils new pathway to speed custom gene editing therapies
Nov 12, 2025 5:00pm
uniQure's gene therapy for Huntington's hits FDA roadblock
Nov 3, 2025 10:03am
After 'complete standstill,' biotech market reaches new normal
Aug 20, 2025 11:04am
Regenxbio's Hunter gene therapy latest to face FDA delay
Aug 19, 2025 10:30am
